Pulmonary Histoplasmosis

ABSTRACT

Pulmonary manifestations of histoplasmosis were last reviewed in Seminars in 2004. This review highlights the management of the most common clinical syndromes, emphasizing recognition, diagnosis, and treatment. The reader is referred to the earlier review for subjects not fully addressed herein. Knowledge of the utility of serological testing is essential, particularly when antigen tests and cultures are negative. Antigen testing is most useful in patients with more diffuse pulmonary involvement and those with progressive disseminated disease due to the high fungal burden. Detection of antigen in bronchoalveolar lavage fluid may be particularly helpful in certain circumstances. Guidelines for antifungal therapy have been updated and will be discussed for pulmonary syndromes.

KEYWORDS

Histoplasmosis - serology - antigen - diagnosis - treatment

REFERENCES

• 1 Wheat L J, Conces D J, Allen S, Blue-Hnidy D, Loyd J. Pulmonary histoplasmosis syndromes: recognition, diagnosis, and management.  Semin Respir Crit Care Med. 2004;  25 129-144
• 2 Kauffman C A. Histoplasmosis: a clinical and laboratory update.  Clin Microbiol Rev. 2007;  20 115-132
• 3 Wheat L J. Improvements in diagnosis of histoplasmosis.  Expert Opin Biol Ther. 2006;  6 1207-1221
• 4 Wheat L J, Kohler R B, Tewari R P. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens.  N Engl J Med. 1986;  314 83-88
• 5 Durkin M M, Connolly P A, Wheat L J. Comparison of radioimmunoassay and enzyme-linked immunoassay methods for detection of Histoplasma capsulatum var. capsulatum antigen.  J Clin Microbiol. 1997;  35 2252-2255
• 6 Wheat J, Wheat H, Connolly P et al.. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses.  Clin Infect Dis. 1997;  24 1169-1171
• 7 Wheat L J, Connolly P, Durkin M et al.. False-positive Histoplasma antigenemia caused by antithymocyte globulin antibodies.  Transpl Infect Dis. 2004;  6 23-27
• 8 Wheat L J, Connolly P, Durkin M, Book B K, Pescovitz M D. Elimination of false-positive Histoplasma antigenemia caused by human anti-rabbit antibodies in the second-generation Histoplasma antigen assay.  Transpl Infect Dis. 2006;  8 219-221
• 9 Wheat L J, Witt III J, Durkin M, Connolly P. Reduction in false antigenemia in the second generation Histoplasma antigen assay.  Med Mycol. 2007;  45 169-171
• 10 Kuberski T, Myers R, Wheat L J, Kubak B M, Bruckner D, Peuges D. Diagnosis of coccidioidomycosis by antigen detection using cross-reaction with a Histoplasma antigen.  Clin Infect Dis. 2007;  44 e50-e54
• 11 Connolly P A, Durkin M M, Lemonte A M, Hackett E J, Wheat L J. Detection of histoplasma antigen by a quantitative enzyme immunoassay.  Clin Vaccine Immunol. 2007;  14 1587-1591
• 12 Williams B, Fojtasek M, Connolly-Stringfield P, Wheat J. Diagnosis of histoplasmosis by antigen detection during an outbreak in Indianapolis, Ind.  Arch Pathol Lab Med. 1994;  118 1205-1208
• 13 Davies S F. Serodiagnosis of histoplasmosis.  Semin Respir Infect. 1986;  1 9-15
• 14 Wheat L J. Current diagnosis of histoplasmosis.  Trends Microbiol. 2003;  11 488-494
• 15 Wheat L J, Garringer T, Brizendine E, Connolly P. Diagnosis of histoplasmosis by antigen detection based upon experience at the histoplasmosis reference laboratory.  Diagn Microbiol Infect Dis. 2002;  43 29-37
• 16 Wheat J, French M L, Kohler R B et al.. The diagnostic laboratory tests for histoplasmosis: analysis of experience in a large urban outbreak.  Ann Intern Med. 1982;  97 680-685
• 17 Sacks J J, Ajello L, Crockett L K. An outbreak and review of cave-associated histoplasmosis capsulati.  J Med Vet Mycol. 1986;  24 313-327
• 18 Hage C A, Davis T E, Egan L et al.. Diagnosis of pulmonary histoplasmosis and blastomycosis by detection of antigen in bronchoalveolar lavage fluid using an improved second-generation enzyme-linked immunoassay.  Respir Med. 2007;  101 43-47
• 19 Wheat L J, Connolly-Stringfield P, Blair R, Connolly K, Garringer T, Katz B P. Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels.  Ann Intern Med. 1991;  115 936-941
• 20 Wheat L J, French M LV. The diagnostic approach in histoplasmosis.  Immunol Allergy Pract V. 1983;  9 19-28
• 21 Larrabee W F, Ajello L, Kaufman L. An epidemic of histoplasmosis on the isthmus of Panama.  Am J Trop Med Hyg. 1978;  27 281-285
• 22 Zimmerman S E, French M LV, Kleiman M B, Wheat L J. Evaluation of an enzyme-linked immunosorbent assay that uses ferrous metal beads for determination of antihistoplasmal immunoglobulins G and M.  J Clin Microbiol. 1990;  28 59-64
• 23 Guimaraes A J, Pizzini C V, Matos Guedes H L et al.. ELISA for early diagnosis of histoplasmosis.  J Med Microbiol. 2004;  53 509-514
• 24 Bialek R, Feucht A, Aepinus C et al.. Evaluation of two nested PCR assays for detection of Histoplasma capsulatum DNA in human tissue.  J Clin Microbiol. 2002;  40 1644-1647
• 25 Tang Y W, Li H, Durkin M M et al.. Urine polymerase chain reaction is not as sensitive as urine antigen for the diagnosis of disseminated histoplasmosis.  Diagn Microbiol Infect Dis. 2006;  54 283-287
• 26 Ost D, Fein A M, Feinsilver S H. The solitary pulmonary nodule.  N Engl J Med. 2003;  348 2535-2542
• 27 Mashburn J D, Dawson D F, Young J M. Pulmonary calcifications and histoplasmosis.  Am Rev Respir Dis. 1961;  84 208-216
• 28 Wheat L J, Freifeld A G, Kleiman M B et al.. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America.  Clin Infect Dis. 2007;  45 807-825
• 29 Reynolds R JI, Penn R L, Grafton W D, George R B. Tissue morphology of Histoplasma capsulatum in acute histoplasmosis.  Am Rev Respir Dis. 1984;  130 317-320
• 30 Sollod N. Acute fulminating disseminated histoplasmosis.  J S C Med Assoc. 1971;  67 231-234
• 31 Sathapatayavongs B, Batteiger B E, Wheat J, Slama T G, Wass J L. Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks.  Medicine (Baltimore). 1983;  62 263-270
• 32 Wheat L J, Slama T G, Norton J A et al.. Risk factors for disseminated or fatal histoplasmosis: analysis of a large urban outbreak.  Ann Intern Med. 1982;  96 159-163
• 33 Wynne J W, Olsen G N. Acute histoplasmosis presenting as the adult respiratory distress syndrome.  Chest. 1974;  66 158-161
• 34 Johnson P C, Wheat L J, Cloud G A et al.. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS.  Ann Intern Med. 2002;  137 105-109
• 35 Goodwin R A, Loyd J E, des Prez R M. Histoplasmosis in normal hosts.  Medicine (Baltimore). 1981;  60 231-266
• 36 Scully R E, Mark E J, McNeely W F, McNeely B U. Case records of the Massachusetts General Hospital: case 39-1991 presentation of case.  N Engl J Med. 1991;  325 949-956
• 37 Greenwood M F, Holland P. Tracheal obstruction secondary to Histoplasma mediastinal granuloma.  Chest. 1972;  62 642-645
• 38 Savides T J, Gress F G, Wheat L J, Ikenberry S, Hawes R H. Dysphagia due to mediastinal granulomas: diagnosis with endoscopic ultrasonography.  Gastroenterology. 1995;  109 366-373
• 39 Jenkins D W, Fisk D E, Byrd R B. Mediastinal histoplasmosis with esophageal abscess.  Gastroenterology. 1976;  70 109-111
• 40 Dines D E, Payne W S, Bernatz P E, Pairolero P C. Mediastinal granuloma and fibrosing mediastinitis.  Chest. 1979;  75 320-324
• 41 Davis A M, Pierson R N, Loyd J E. Mediastinal fibrosis.  Semin Respir Infect. 2001;  16 119-130
• 42 Goodwin R A, Nickell J A, des Prez R M. Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis.  Medicine (Baltimore). 1972;  51 227-246
• 43 Weinstein J B, Aronberg D J, Sagel S S. CT of fibrosing mediastinitis: findings and their utility.  AJR Am J Roentgenol. 1983;  141 247-251
• 44 Loyd J E, Tillman B F, Atkinson J B, des Prez R M. Mediastinal fibrosis complicating histoplasmosis.  Medicine (Baltimore). 1988;  67 295-310
• 45 Doyle T P, Loyd J E, Robbins I M. Percutaneous pulmonary artery and vein stenting: a novel treatment for mediastinal fibrosis.  Am J Respir Crit Care Med. 2001;  164 657-660
• 46 Recto M R, Bousamra M, Yeh T. Late superior vena cava perforation and aortic laceration after stenting to treat superior vena cava syndrome secondary to fibrosing mediastinitis.  J Invasive Cardiol. 2002;  14 624-629
• 47 Mathisen D J, Grillo H C. Clinical manifestations of mediastinal fibrosis and histoplasmosis.  Ann Thorac Surg. 1992;  54 1053-1058
• 48 Wheat L J, Slama T G, Eitzen H E, Kohler R B, French M L, Biesecker J L. A large urban outbreak of histoplasmosis: clinical features.  Ann Intern Med. 1981;  94 331-337
• 49 Wheat L J, Wass J, Norton J, Kohler R B, French M L. Cavitary histoplasmosis occurring during two large urban outbreaks: analysis of clinical, epidemiologic, roentgenographic, and laboratory features.  Medicine (Baltimore). 1984;  63 201-209
• 50 Goodwin Jr R A, Owens F T, Snell J D et al.. Chronic pulmonary histoplasmosis.  Medicine (Baltimore). 1976;  55 413-452
• 51 Furcolow M L. Comparison of treated and untreated severe histoplasmosis.  JAMA. 1963;  183 121-127
• 52 Putnam L R, Sutliff W D, Larkin J C et al.. Histoplasmosis cooperative study: chronic pulmonary histoplasmosis treated with amphotericin B alone and with amphotericin B and triple sulfonamide.  Am Rev Respir Dis. 1968;  97 96-102
• 53 Adderson E E. Histoplasmosis in a pediatric oncology center.  J Pediatr. 2004;  144 100-106
• 54 Wheat L J, Smith E J, Sathapatayavongs B et al.. Histoplasmosis in renal allograft recipients: two large urban outbreaks.  Arch Intern Med. 1983;  143 703-707
• 55 Freifeld A G, Iwen P C, Lesiak B L, Gilroy R K, Stevens R B, Kalil A C. Histoplasmosis in solid organ transplant recipients at a large midwestern university transplant center.  Transpl Infect Dis. 2005;  7 109-115
• 56 Wheat J. Histoplasmosis in the acquired immunodeficiency syndrome.  Curr Top Med Mycol. 1996;  7 7-18
• 57 Tucker R M, Denning D W, Hanson L H et al.. Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.  Clin Infect Dis. 1992;  14 165-174
• 58 Odio C M, Navarrete M, Carrillo J M, Mora L, Carranza A. Disseminated histoplasmosis in infants.  Pediatr Infect Dis J. 1999;  18 1065-1068
• 59 Leggiadro R J, Barrett F F, Hughes W T. Disseminated histoplasmosis of infancy.  Pediatr Infect Dis J. 1988;  7 799-805
• 60 Goodwin Jr R A, Shapiro J L, Thurman G H, Thurman S S, des Prez R M. Disseminated histoplasmosis: clinical and pathologic correlations.  Medicine (Baltimore). 1980;  59 1-33
• 61 Wood K L, Hage C A, Knox K S et al.. Histoplasmosis after treatment with anti-TNF-α therapy.  Am J Respir Crit Care Med. 2003;  167 1279-1282
• 62 Lee J H, Slifman N R, Gershon S K et al.. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept.  Arthritis Rheum. 2002;  46 2565-2570
• 63 Wallis R S, Broder M S, Wong J Y, Hanson M E, Beenhouwer D O. Granulomatous infectious diseases associated with tumor necrosis factor antagonists.  Clin Infect Dis. 2004;  38 1261-1265
• 64 Kortsik C, Elmer A, Tamm I. Pleural effusion due to Histoplasma capsulatum and idiopathic CD4 lymphocytopenia.  Respiration. 2003;  70 118-122
• 65 Zerbe C S, Holland S M. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency.  Clin Infect Dis. 2005;  41 e38-e41
• 66 Conces Jr D J, Stockberger S M, Tarver R D, Wheat L J. Disseminated histoplasmosis in AIDS: findings on chest radiographs.  AJR Am J Roentgenol. 1993;  160 15-19
• 67 Corcoran G R, Al-Abdely H, Flanders C D, Geimer J, Patterson T F. Markedly elevated serum lactate dehydrogenase levels are a clue to the diagnosis of disseminated histoplasmosis in patients with AIDS.  Clin Infect Dis. 1997;  24 942-944
• 68 Kirn D H, Fredericks D, McCutchan J A, Stites D, Shuman M. Serum ferritin levels correlate with disease activity in patients with AIDS and disseminated histoplasmosis.  Clin Infect Dis. 1995;  21 1048-1049
• 69 Sarosi G A, Voth D W, Dahl B A, Doto I L, Tosh F E. Disseminated histoplasmosis: results of long-term follow-up: a Center for Disease Control Cooperative Mycoses Study.  Ann Intern Med. 1971;  75 511-516
• 70 Johnson P C, Wheat L J, Cloud G A et al.. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS.  Ann Intern Med. 2002;  137 105-109
• 71 Dismukes W E, Bradsher R W, Cloud G C et al.. Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group.  Am J Med. 1992;  93 489-497
• 72 Wheat J, Hafner R, Korzun A H et al.. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group.  Am J Med. 1995;  98 336-342
• 73 Wheat J, Hafner R, Wulfsohn M et al.. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. The National Institute of Allergy and Infectious Diseases Clinical Trials and Mycoses Study Group Collaborators.  Ann Intern Med. 1993;  118 610-616
• 74 Hecht F M, Wheat J, Korzun A H et al.. Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial.  J Acquir Immune Defic Syndr Hum Retrovirol. 1997;  16 100-107
• 75 Goldman M, Zackin R, Fichtenbaum C J et al.. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy.  Clin Infect Dis. 2004;  38 1485-1489
• 76 Wheat L J, Connolly P, Smedema M et al.. Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole.  J Antimicrob Chemother. 2006;  57 1235-1239
• 77 Connolly P, Wheat L J, Schnizlein-Bick C et al.. Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice.  Antimicrob Agents Chemother. 2000;  44 2604-2608
• 78 Connolly P, Wheat J, Schnizlein-Bick C et al.. Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.  Antimicrob Agents Chemother. 1999;  43 322-328
• 79 Restrepo A, Tobon A, Clark B et al.. Salvage treatment of histoplasmosis with posaconazole.  J Infect. 2007;  54 319-327
• 80 Wheat J, MaWhinney S, Hafner R et al.. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group.  Am J Med. 1997;  103 223-232
• 81 Wheat L J, Connolly P, Smedema M, Brizendine E, Hafner R. Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome.  Clin Infect Dis. 2001;  33 1910-1913
• 82 Walsh T J, Raad I, Patterson T F et al.. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.  Clin Infect Dis. 2007;  44 2-12
• 83 Freifeld A, Arnold S, Ooi W et al.. Relationship of blood level and susceptibility in voriconazole treatment of histoplasmosis.  Antimicrob Agents Chemother. 2007;  51 2656-2657